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Only recently, the prevalence of sensitization to carrot in 13.000 German children aged 3--17 years was shown to be 8% [1](#all12938-bib-0001){ref-type="ref"}. Carrot allergy is generally considered a birch pollen‐related food allergy with Dau c 1 as major allergen [2](#all12938-bib-0002){ref-type="ref"}. Birch pollen‐related food allergy results from primary sensitization to the major birch pollen allergen followed by cross‐reactivity of Bet v 1‐specific IgE antibodies and T cells with Bet v 1‐related food proteins [3](#all12938-bib-0003){ref-type="ref"}, [4](#all12938-bib-0004){ref-type="ref"}, [5](#all12938-bib-0005){ref-type="ref"}, [6](#all12938-bib-0006){ref-type="ref"}. Consequently, Bet v 1 and homologous food allergens are usually not considered to show sensitizing activity. Dau c 1 possesses an amino acid (aa) sequence similarity of 61% (38% identity) with Bet v 1 and shows a similar 3‐dimensional structure [7](#all12938-bib-0007){ref-type="ref"}, [8](#all12938-bib-0008){ref-type="ref"}. However, comparisons of the surface topology and physicochemical properties of Dau c 1 and Bet v 1 have revealed that the two proteins share only some but not all IgE epitopes [8](#all12938-bib-0008){ref-type="ref"}. Indeed, IgE binding to Dau c 1 could not be inhibited by Bet v 1 in a subset of birch pollen‐allergic patients with carrot allergy [9](#all12938-bib-0009){ref-type="ref"}. This observation clearly differed from other Bet v 1‐related food allergens, in particular from Api g 1 in celery, which has an aa sequence similarity of 93% (81% identity) with Dau c 1 [7](#all12938-bib-0007){ref-type="ref"}. In contrast to Dau c 1, IgE binding to Api g 1 is completely abolished by Bet v 1 [10](#all12938-bib-0010){ref-type="ref"}, [11](#all12938-bib-0011){ref-type="ref"}. Additional evidence for a Bet v 1‐independent Dau c 1‐specific IgE response has been provided by the detection of significant Dau c 1‐specific IgE levels in 4 adult patients with strong immediate systemic reactions to raw carrot who displayed no Bet v 1‐specific IgE antibodies [12](#all12938-bib-0012){ref-type="ref"}. The same applied to two patients with carrot‐induced asthma [13](#all12938-bib-0013){ref-type="ref"}. Together, these data provided evidence that Dau c 1 might initiate food allergy independently from the major birch pollen allergen making it an atypical Bet v 1‐related food allergen.

Allergen‐specific CD4^+^ T cells are crucial in the sensitization process of IgE‐mediated allergy as clonal expansion of allergen‐specific Th2 cells that produce IL‐4 and IL‐13 promotes B‐cell class switching to the production of allergen‐specific IgE antibodies. As information on the T‐cell response to the carrot allergen is scarce, we characterized Dau c 1‐specific T‐cell lines (TCL) and clones (TCC) expanded from PBMC of Bet v 1‐ and Dau c 1‐sensitized birch pollen‐allergic patients with carrot allergy regarding their phenotype and cross‐reactivity with the major birch pollen allergen. To gain insight into the possible priming sites of Dau c 1‐specific T cells, we compared the expression of the integrins β7 and β1 on the surface of Dau c 1‐specific TCC cross‐reactive and nonreactive with Bet v 1. The gut‐homing factor integrin α4β7 binds to the key intestinal mucosal addressin cell adhesion molecule‐1 (MAdCAM‐1) [14](#all12938-bib-0014){ref-type="ref"} and has been shown to be expressed on milk allergen‐specific T cells and peanut‐specific TCC [15](#all12938-bib-0015){ref-type="ref"}, [16](#all12938-bib-0016){ref-type="ref"}. In contrast, the α4β1‐integrin (very late antigen‐4) has been implicated in the recruitment of T cells to extraintestinal sites of inflammation, such as lungs and skin [17](#all12938-bib-0017){ref-type="ref"}. We also determined T‐cell‐activating regions of Dau c 1 and subjected the protein to endolysosomal degradation as stability to lysosomal proteolysis has been considered a relevant factor for immunogenicity [18](#all12938-bib-0018){ref-type="ref"}, [19](#all12938-bib-0019){ref-type="ref"}. The resulting proteolytic fragments were sequenced by mass spectrometry and compared with the identified T‐cell‐activating regions.

Methods {#all12938-sec-0006}
=======

Allergens and peptides {#all12938-sec-0007}
----------------------

Recombinant Dau c 1, Bet v 1, Api g 1, and Mal d 1 were purchased from Biomay (Vienna, Austria). Recombinant Cor a 1 was provided by S. Scheurer (Paul Ehrlich Institute, Langen, Germany). A panel of 48 synthetic 12‐mer peptides overlapping by 9 aa and representing the entire aa sequence of Dau c 1 was purchased from Thermo Fisher Scientific (Uppsala, Sweden).

Allergic patients {#all12938-sec-0008}
-----------------

We included 31 patients with birch pollen allergy proven by typical case history and birch pollen‐specific IgE levels of \>0.35 kU~A~/L (ImmunoCAP; Thermo Fisher Scientific). All patients reported allergic symptoms after ingestion of raw carrot. In addition, patients 1, 5, 10, 13, and 20 had been positive in double‐blind placebo‐controlled food challenges with carrot [9](#all12938-bib-0009){ref-type="ref"}. All patients displayed Dau c 1‐specific IgE as determined by ELISA (data not shown). The study was approved by the local ethics committees and all donors provided written informed consent.

Dau c 1‐specific T‐cell lines (TCL) {#all12938-sec-0009}
-----------------------------------

PBMC (1.5 × 10^6^) were stimulated with Dau c 1 (5 μg/ml). Cultures without Dau c 1 served as controls. After 4 days, human rIL‐2 (10 U/ml; Roche, Basel, Switzerland) was added. After another 4 days, viable T‐cell blasts were enriched by density centrifugation and subjected to the cloning procedure. Remaining blasts were expanded with rIL‐2 (10 U/ml, Boehringer Mannheim, Mannheim, Germany) and irradiated PBMC (1 × 10^5^) in 200 μl UltraCulture Medium (BioWhittaker, Walkersville, MD, USA) supplemented with 2 mM glutamine, 2 × 10^−5^ M 2‐mercaptoethanol, and gentamicin (Lonza, Basel, Switzerland). After sufficient cell numbers were obtained, cells were rested for 14 days and stimulated with recombinant allergens (each 5 μg/ml) or synthetic 12mer peptides (5 μg/ml) in the presence of irradiated autologous PBMC. After 48 h, proliferative responses were determined by ^3^H‐thymidine incorporation assay. The stimulation index (SI) was calculated as ratio between counts per minute (cpm) obtained in cultures with TCL plus autologous PBMC plus allergen/peptide and cpm obtained in cultures containing only TCL plus autologous PBMC.

Dau c 1‐specific T‐cell clones {#all12938-sec-0010}
------------------------------

T‐cell blasts from Dau c 1‐specific TCL were seeded by means of limiting dilution technique in 96‐well round‐bottomed plates (Nunclon; Nunc, Copenhagen, Denmark) in the presence of irradiated PBMC/0.2% v/v PHA (GE Healthcare, Little Chalfont, UK) and rIL‐2 (4 U/well) in the medium described above. Grown clones were screened for allergen specificity by incubation with Dau c 1 (5 μg/ml) in the presence of irradiated autologous PBMC. TCC in medium alone and PBMC without TCC served as controls. The supernatants of clones that reacted to Dau c 1 (SI \> 10) were harvested after 24 h, and cytokine levels were determined using the Luminex System 100 (Luminex, Austin, TX, USA). A ratio of IFN‐γ/IL‐4 \> 5 was classified as Th1‐like, 0.2--5 as Th0, and \<0.2 as Th2‐like. These clones were expanded by alternating turns of stimulation with irradiated PBMC plus either allergen or IL‐2 and as soon as possible tested for cross‐reactivity and epitope specificity as described above for TCL. In addition, TCC were stained with CD3‐APC (BD Bioscience, Franklin Lakes, NJ, USA), CD4‐PerCP (eBioscience, San Diego, CA, USA), TCRαβ‐FITC and integrin β7‐PE (BD Pharmingen, San Jose, CA, USA), and integrin β1‐FITC (Beckman Coulter, Brea, CA, USA) or isotype‐matched antibodies as negative controls.

Detection of GATA3 and Tbet expression {#all12938-sec-0011}
--------------------------------------

PBMC were stained with 0.5 μM CFSE (Invitrogen, Camarillo, CA, USA) and stimulated with either Bet v 1 or Dau c 1 (10 μg/ml) in AIM‐V medium (Invitrogen). After 8 days, CD3^+^CD4^+^CFSE^low^ cells were sorted using a MoFlo Astrios (Beckman Coulter) cell sorter. RNA of sorted cells was isolated using RNeasy Mini Kit (Qiagen, Hamburg, Germany) and reversely transcribed with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer\'s protocol. Quantitative real‐time PCR was performed with Power SYBR Green Master Mix (Applied Biosystems) and published primers for EF‐1α (endogenous control), GATA3, and Tbet [20](#all12938-bib-0020){ref-type="ref"} in an ABI 7900 HT Sequence Detection System (Applied Biosystems). All amplifications were performed in triplicate. Relative quantification was performed using DataAssist Software v2.0 (Applied Biosystems).

Endolysosomal degradation assay {#all12938-sec-0012}
-------------------------------

Dau c 1 (5 μg) and Api g 1 (5 μg) were incubated with microsomal enzyme extracts (7 μg) isolated from monocyte‐derived dendritic cells as described previously [21](#all12938-bib-0021){ref-type="ref"}. Proteolysis was stopped after 1, 3, 6, 12, 24, 36, or 48 h by heat denaturation, and samples were analyzed by SDS‐PAGE (15%) and mass spectrometry using a Q‐Exactive mass spectrometer (Thermo Fisher Scientific) coupled to a capillary rpHPLC (Dionex, Germering, Germany). Peptides were identified using PEAKS Studio 7.0 (Bioinformatics Solutions, Waterloo, ON, Canada).

Results {#all12938-sec-0013}
=======

T‐cell epitopes of Dau c 1 {#all12938-sec-0014}
--------------------------

In total, Dau c 1‐specific TCL from 20 different patients could be expanded and subjected to epitope mapping experiments. Proliferative responses with SI \> 2 were considered positive (Fig. [1](#all12938-fig-0001){ref-type="fig"}). Several peptides within the regions Dau c 1~4--21~, Dau c 1~16--30~, Dau c 1~28--48~, Dau c 1~43--54~, Dau c 1~49--69~, Dau c 1~70--96~, and Dau c 1~91--144~ were recognized by one or two patients. Three patients (15%) harbored T cells reacting to peptides located at Dau c 1~25--36~, Dau c 1~46--57~, Dau c 1~61--72~, Dau c 1~67--78~, and Dau c 1~136--147~. Dau c 1~88--99~ was recognized by four patients (20%). Eleven of 20 (55%) Dau c 1‐specific TCL showed proliferative responses to peptides covering the region Dau c 1~139--153~. The peptides covering aa 1--12, 13--24, 22--33, 40--51, and 64--75 did not induce proliferation in any of the Dau c 1‐specific TCL.

![T‐cell‐activating regions of Dau c 1. Proliferation of Dau c 1‐specific TCL from 20 different patients in response to 48 overlapping peptides spanning the aa sequence of Dau c 1 is shown. Peptides inducing SI \> 2 are denoted in black.](ALL-72-244-g001){#all12938-fig-0001}

Cross‐reactivity of Dau c 1‐specific T‐cell lines with Bet v 1 and homologous food allergens {#all12938-sec-0015}
--------------------------------------------------------------------------------------------

Fifteen Dau c 1‐specific TCL were additionally stimulated with Bet v 1, Api g 1 (celery), Mal d 1 (apple), and Cor a 1 (hazelnut), and proliferative responses were determined (Table [1](#all12938-tbl-0001){ref-type="table-wrap"}). Considering SI \> 2 positive, 6 of 15 (40%) Dau c 1‐specific TCL cross‐reacted with Bet v 1. Moreover, 7 of 14 (50%) Dau c 1‐specific TCL reacted to Api g 1, 5 of 11 (45%) recognized Mal d 1, and 7 of 15 TCL (47%) cross‐reacted with Cor a 1 (Table [1](#all12938-tbl-0001){ref-type="table-wrap"}).

###### 

Reactivity of Dau c 1‐specific TCL with Bet v 1 and homologous food allergens

  Pat. no.   1[\*](#all12938-note-0002){ref-type="fn"}            2         3         6          7         8          9          10        12        13        15        17        18        19        20
  ---------- ---------------------------------------------------- --------- --------- ---------- --------- ---------- ---------- --------- --------- --------- --------- --------- --------- --------- ----------
  Dau c 1    **2.4** [\*\*](#all12938-note-0002){ref-type="fn"}   **6.3**   **2.6**   **12.9**   **3.8**   **11.6**   **107**    **2.1**   **3.0**   **2.1**   **6.3**   **4.4**   **5.5**   **6.1**   **29.3**
  Bet v 1    1.0                                                  0.9       1.0       1.1        1.0       **3.5**    **87.3**   **2.5**   **2.2**   0.9       1.4       **2.5**   1.7       1.4       **4.2**
  Api g 1    0.9                                                  1.9       1.1       **14.8**   1.7       **3.1**    **13.4**   1.4       **2.8**   0.8       n.d.      **2.7**   **3.9**   1.0       **19.4**
  Mal d 1    n.d.                                                 0.8       1.0       0.5        0.7       **13.2**   **64.8**   n.d.      0.5       n.d.      n.d.      1.4       **2.8**   **3.5**   **8.2**
  Cor a 1    1.2                                                  1.7       1.5       **10.3**   **2.7**   0.9        **6.9**    1.1       1.4       1.3       **2.2**   **2.3**   **3.9**   0.8       **3.1**

\*Same patient numbering as in Fig. [1](#all12938-fig-0001){ref-type="fig"}, \*\*positive responses are shown in bold; n.d. not determined.

John Wiley & Sons, Ltd

Characterization of Dau c 1‐specific T‐cell clones {#all12938-sec-0016}
--------------------------------------------------

In total, 22 CD3^+^CD4^+^TCRαβ^+^ Dau c 1‐specific TCC were expanded from 15 different donors (Table [2](#all12938-tbl-0002){ref-type="table-wrap"}). Twenty‐one TCC could be tested for cross‐reactivity with Bet v 1 and 9 (43%) were positive. Five of these TCC had lost their reactivity to Dau c 1 but still responded strongly to Bet v 1. Similarly, we have previously observed that TCC expanded with Mal d 1 and Api g 1 became nonreactive to the food allergens during the *in vitro* expansion process but remained reactive with Bet v 1 [4](#all12938-bib-0004){ref-type="ref"}, [11](#all12938-bib-0011){ref-type="ref"}. Analysis of the levels of IL‐4, IFN‐γ, and IL‐10 in response to stimulation with Dau c 1 revealed that 6 clones (27%) belonged to the Th2 subset, 10 TCC (45%) were Th1‐like, and six clones (27%) were classified as Th0 clones (Table [2](#all12938-tbl-0002){ref-type="table-wrap"}). Thirteen TCC (59%) synthesized IL‐10 (\>50 pg/ml). Six Dau c 1‐specific TCC could be expanded to cell numbers sufficient for epitope mapping (Table [2](#all12938-tbl-0002){ref-type="table-wrap"}). Three clones (50%) recognized the C‐terminal region Dau c 1~139--153~, two TCC reacted to the peptide Dau c 1~34--48~, and one TCC reacted to Dau c 1~67--78~.

###### 

Characterization of Dau c 1‐specific TCC

       TCC       Stimuli    Cytokines \[pg/ml\]                                 Subset   Peptide                            
  ---- --------- ---------- --------------------------------------------------- -------- --------- ------- ----- ---------- -----------------
  1    P1 36     1.1        **35.4** [\*](#all12938-note-0003){ref-type="fn"}   198      500       180     Th0   n.d.       
  2    P2 137    1.0        **181**                                             406      \<9.5     370     Th2   34--48     APGAYKSVEVKGDGG
  3    P3 5      1.6        **91**                                              425      \<9.5     502     Th2   n.d.       
  4    P3 13     **112**    2.1                                                 230      \<9.5     260     Th2   139--153   NTALFKAIEAYLIAN
  5    P3 56     0.8        **36.2**                                            27.0     \<9.5     63.1    Th0   n.d.       
  6    P3 66     0.9        **5.1**                                             \<0.9    510       33.2    Th1   n.d.       
  7    P4 17     **2.0**    **2.6**                                             \<0.9    173       \<7.5   Th1   n.d.       
  8    P4 29     **2.5**    **2.4**                                             \<0.9    \<9.5     \<7.5   Th0   n.d.       
  9    P5 2      **2.1**    **2.0**                                             \<0.9    21.1      \<7.5   Th0   n.d.       
  10   P6 2      **13.0**   0.5                                                 339      \<9.5     15.8    Th2   142--153   LFKAIEAYLIAN
  11   P6 3      **8.9**    **2.7**                                             \<0.9    \<9.5     \<7.5   Th0   n.d.       
  12   P7 54     **3.9**    0.6                                                 \<0.9    \<9.5     692     Th0   34--48     APGAYKSVEVKGDGG
  13   P8 117    **15.4**   1.1                                                 17.2     2319      118     Th1   67--78     TVRTDAVNKEAL
  14   P9 16     **40.4**   1.0                                                 \<0.9    502       100     Th1   n.d.       
  15   P10 41    **4.7**    1.1                                                 \<0.9    102       17.1    Th1   n.d.       
  16   P12 36    **2.3**    0.8                                                 12 296   536       81.7    Th2   n.d.       
  17   P12 84    **5.2**    0.7                                                 213      1377      32.3    Th1   n.d.       
  18   P13 52    **7.4**    1.8                                                 \<0.9    172       20.1    Th1   n.d.       
  19   P14 145   **48.1**   1.0                                                 \<0.9    424       190     Th1   n.d.       
  20   P14 149   **28.4**   0.6                                                 423      \<9.5     60.5    Th2   139--153   NTALFKAIEAYLIAN
  21   P15 55    **50.0**   0.8                                                 \<0.9    523       112     Th1   n.d.       
  22   P17 62    **10.5**   n.d.                                                \<0.9    1946      \<7.5   Th1   n.d.       

\*Positive responses are shown in bold, n.d. not determined.

John Wiley & Sons, Ltd

Ten Dau c 1‐specific TCC from 6 different patients could be analyzed for the expression of integrins β7 and β1 (Table [3](#all12938-tbl-0003){ref-type="table-wrap"}). As observed previously, TCC constitutively expressed both integrins independently from their activation status [16](#all12938-bib-0016){ref-type="ref"}. However, Bet v 1‐nonreactive TCC showed a slightly higher surface expression of integrin β7 and a significantly lower expression of integrin β1 (CD29, *P* = 0.032, Mann--Whitney *U*‐test) than Bet v 1‐cross‐reactive Dau c 1‐specific TCC.

###### 

Integrin expression of Bet v 1‐reactive and nonreactive Dau c 1‐specific TCC

  TCC      Proliferation (SI) to   Subset   Expression (MFI) of   TCC    Proliferation (SI) to                          Subset    Expression (MFI) of                      
  -------- ----------------------- -------- --------------------- ------ ---------------------------------------------- --------- --------------------- ----- ----- ------ ---------------------------------------------
  P1 36    1.1                     35.4     Th0                   547    839                                            P3 13     112                   2.1   Th2   201    174
  P2 137   1.0                     181      Th2                   184    1564                                           P9 16     40.4                  1.0   Th1   412    541
  P3 5     1.6                     91       Th2                   280    1341                                           P10 41    4.7                   1.1   Th1   1075   636
  P3 56    0.8                     36.2     Th0                   554    851                                            P14 137   207                   1.1   Th1   886    330
  P3 66    0.9                     5.1      Th1                   1059   1666                                           P14 145   48.1                  1.0   Th1   1038   974
  Median                                                          547    1341[\*](#all12938-note-0004){ref-type="fn"}   Median                                      886    541[\*](#all12938-note-0004){ref-type="fn"}

MFI, mean fluorescence intensity; \**P* \< 0.05, Mann--Whitney *U*‐test.

John Wiley & Sons, Ltd

Th subsets in Dau c 1^+^Bet v 1^+^ and Dau c 1^+^Bet v 1^−^ TCC {#all12938-sec-0017}
---------------------------------------------------------------

By comparing the subset distribution of Bet v 1‐reactive and nonreactive Dau c 1‐specific TCC, we found that 7 of 12 (58%) Bet v 1^−^ and 2 of 9 (22%) Bet v 1^+^ clones were Th1‐like (Table [2](#all12938-tbl-0002){ref-type="table-wrap"}). Furthermore, 8 of 12 (67%) Bet v 1^−^ clones produced IL‐10 in contrast to 4 of 9 (44%) Bet v 1^+^ TCC. These data pointed to a difference in effector function between Bet v 1‐cross‐reactive and nonreactive TCC.

To confirm the discrepancy in cytokine production of Dau c 1‐ and Bet v 1‐reactive clones in specific polyclonal T cells, we analyzed the mRNA expression of the major transcription factors for Th2 (GATA3) and Th1 (Tbet) in CD4^+^CD3^+^ cells that proliferated upon a single stimulation of PBMC with either allergen. However, due to the very low frequency of allergen‐specific T cells in the periphery, sufficient numbers of proliferating CD4^+^ T cells could be sorted from solely three individuals (Fig. [2](#all12938-fig-0002){ref-type="fig"}). Nevertheless, a higher expression of Tbet was detected in Dau c 1‐reactive CFSE^low^CD4^+^CD3^+^ cells when compared to CFSE^low^CD4^+^CD3^+^ cells in cultures stimulated with Bet v 1. *Vice versa*, Bet v 1‐reactive T cells expressed higher levels of GATA3 (Fig. [2](#all12938-fig-0002){ref-type="fig"}).

![Dau c 1‐reactive T cells are Th1‐like. CFSE‐stained PBMC of three allergic patients were stimulated once with Dau c 1 or Bet v 1. After 8 days, proliferated CD3^+^CD4^+^CFSE^low^ cells were sorted and analyzed for mRNA expression of Tbet or GATA3 by qPCR. Fold changes of Dau c 1‐stimulated T cells to normalized values of Bet v 1‐stimulated T cells are shown.](ALL-72-244-g002){#all12938-fig-0002}

Endolysosomal degradation of Dau c 1 {#all12938-sec-0018}
------------------------------------

The characterization of the T‐cell response to Dau c 1 indicated that the carrot allergen differed from other Bet v 1‐related food allergens, in particular from the highly homologous celery allergen Api g 1. Api g 1 lacks a major T‐cell‐activating region and displays strong cellular cross‐reactivity with Bet v 1 [11](#all12938-bib-0011){ref-type="ref"}. To check whether this divergence resulted from differences in antigen processing, we compared the endolysosomal proteolysis of both proteins (Fig. [3](#all12938-fig-0003){ref-type="fig"}A). Api g 1 was degraded faster and only detectable for 12 h, whereas full‐length Dau c 1 was still detectable at 48 h. We also sequenced the proteolytic fragments of Dau c 1 after 1, 3, 6, 12, 24, and 48 h (Fig. [3](#all12938-fig-0003){ref-type="fig"}B). Peptide clusters within the regions Dau c 1~23--34~, Dau c 1~92--101~, and Dau c 1~127--149~ were detected after 1 h of incubation. After 3 h, additional clusters within Dau c 1~10--22~, Dau c 1~41--57~, Dau c 1~103--115~, and Dau c 1~118--134~ were identified and complemented by Dau c 1~68--78~ after 12 h. Overall, the proteolytic peptide clusters matched the T‐cell‐activating regions identified in Dau c 1‐specific TCL (Fig. [1](#all12938-fig-0001){ref-type="fig"}). The most frequently recognized region Dau c 1~139--153~ appeared after 1 h of endolysosomal degradation.

![Endolysosomal degradation of Dau c 1. (A) Dau c 1 and Api g 1 were incubated with endolysosomal proteases for indicated time periods and analyzed by SDS‐PAGE (15%) and Coomassie staining. M, marker proteins; CI, proteases without allergen; CII, allergen without proteases; (B). Dau c 1‐derived peptide sequences after endolysosomal proteolysis for 1, 3, 6, 12, 24, 36, and 48 h. Each line represents a unique peptide found. T‐cell‐activating regions recognized by \>15% of the patients are framed in the aa sequence of Dau c 1.](ALL-72-244-g003){#all12938-fig-0003}

Discussion {#all12938-sec-0019}
==========

In the past, we and others have characterized the T‐cell response to Api g 1, Cor a 1, and Mal d 1, and their cellular cross‐reactivity with the major birch pollen allergen [4](#all12938-bib-0004){ref-type="ref"}, [11](#all12938-bib-0011){ref-type="ref"}, [21](#all12938-bib-0021){ref-type="ref"}, [22](#all12938-bib-0022){ref-type="ref"}, [23](#all12938-bib-0023){ref-type="ref"}, [24](#all12938-bib-0024){ref-type="ref"}. These studies have shown that T lymphocytes reactive with these food allergens are mainly cross‐reactive Bet v 1‐specific T cells. Here, we applied the same approach to study Dau c 1‐specific T cells and provide strong evidence that the major carrot allergen may induce T‐cell responses independently from Bet v 1. These findings complement previous findings on Bet v 1‐independent IgE responses to Dau c 1 in carrot‐allergic individuals [9](#all12938-bib-0009){ref-type="ref"}, [12](#all12938-bib-0012){ref-type="ref"}, [13](#all12938-bib-0013){ref-type="ref"}.

Most surprisingly, the T‐cell response to Dau c 1 differed notably from Api g 1 although both proteins have 93% aa sequence similarity [7](#all12938-bib-0007){ref-type="ref"}. Api g 1 is devoid of immunodominant T‐cell‐activating regions recognized by more than 50% of birch pollen‐allergic individuals with celery allergy [11](#all12938-bib-0011){ref-type="ref"}. In contrast, the region Dau c 1~139--153~ was recognized by 55% of the patients in this study (Fig. [1](#all12938-fig-0001){ref-type="fig"}). The same region had already previously attracted our attention as the majority of Cor a 1‐specific TCC reactive to epitopes located within aa 142--153 cross‐reacted with Dau c 1 but not with Bet v 1 [22](#all12938-bib-0022){ref-type="ref"}. In the present study, all seven Cor a 1‐reactive Dau c 1‐specific TCL harbored T cells specific for epitopes within aa 142--153 and four of them did not react to Bet v 1. These findings demonstrate the existence of food‐specific T‐cell epitopes in the immunodominant region Dau c 1~142--153~ that are shared with the major allergen in hazelnut but not with Bet v 1.

We recently have found that the sensitizing activity of Bet v 1‐related food allergens correlates with the presence of immunodominant T‐cell‐activating regions [21](#all12938-bib-0021){ref-type="ref"}. The nonsensitizing proteins Api g 1 and Mal d 1 lack major T‐cell epitopes, whereas the major sensitizer Bet v 1 contains the region Bet v 1~142--156~ recognized by 63% of birch pollen‐allergic patients. Dau c 1 confirms these findings as it contains an immunodominant T‐cell‐activating region and induces IgE responses independently from Bet v 1 [9](#all12938-bib-0009){ref-type="ref"}, [12](#all12938-bib-0012){ref-type="ref"}, [13](#all12938-bib-0013){ref-type="ref"}. Beyond that, a high proportion of Dau c 1 remained intact for 48 h of incubation with endolysosomal proteases (Fig. [3](#all12938-fig-0003){ref-type="fig"}A). This behavior is characteristic for immunogenic proteins [19](#all12938-bib-0019){ref-type="ref"} and again more similar to Bet v 1 [18](#all12938-bib-0018){ref-type="ref"} than to Api g 1 which was degraded after 24 h (Fig. [3](#all12938-fig-0003){ref-type="fig"}B). The higher stability of Dau c 1 to endolysosomal processing compared with Api g 1 might be one explanation for its potential allergenicity.

Dau c 1 and Api g 1 also differed significantly regarding cellular cross‐reactivity with Bet v 1. Less than 43% of Dau c 1‐specific TCL and TCC cross‐reacted with the major birch pollen allergen (Tables [1](#all12938-tbl-0001){ref-type="table-wrap"} and [2](#all12938-tbl-0002){ref-type="table-wrap"}), whereas 12 of 12 (100%) TCL and 11 of 13 (85%) TCC specific for Api g 1 responded to stimulation with Bet v 1 [11](#all12938-bib-0011){ref-type="ref"}. Along these lines, Hofmann et al. [24](#all12938-bib-0024){ref-type="ref"} had also observed a limited extent of cross‐reactivity between Dau c 1 and Bet v 1. In addition, we found divergent phenotypes of T cells specific for each allergen. The majority of Bet v 1‐cross‐reactive Dau c 1‐specific T cells were Th2/Th0‐like (Table [2](#all12938-tbl-0002){ref-type="table-wrap"}). In contrast, most non‐cross‐reactive Dau c 1‐specific T cells belonged to the Th1 subset. We confirmed the more Th1‐like response to Dau c 1 in primary cultures. Sorted T cells proliferating upon a single stimulation with Dau c 1 expressed higher mRNA levels of the Th1 transcription factor Tbet and lower levels of the Th2 transcription factor GATA3 than T cells proliferating upon stimulation with Bet v 1 (Fig. [2](#all12938-fig-0002){ref-type="fig"}). Notably, all Dau c 1‐specific TCC specific for the major T‐cell‐activating region Dau c 1~139--153~ and nonreactive with Bet v 1 showed a Th2‐like phenotype (Table [2](#all12938-tbl-0002){ref-type="table-wrap"}). Very recent data demonstrated that cutaneous sensitization of mice to the model allergen papain depended on mast cells and was independent from IL‐33 [25](#all12938-bib-0025){ref-type="ref"}. In contrast, inhalant sensitization to papain involved IL‐33 [26](#all12938-bib-0026){ref-type="ref"}. Along these lines, we speculate that distinct routes of sensitization involving different pathways, cell types and cytokines may also result in a different distribution of allergen‐specific Th subsets. For example, inhalant sensitization might promote the differentiation of a high proportion of Th2 cells and only a few Th1 cells whereas cutaneous sensitization might promote a more equal but still Th2‐dominated distribution of both subsets. Birth cohort studies provide increasing evidence that sensitization to food allergens happens in early life *via* the skin and gut. These routes of sensitization might also be relevant for Dau c 1 as carrots are frequently consumed by little children who have higher gastric pH values that will impair complete degradation of Bet v 1 and homologous food allergens. Indeed, Bet v 1‐cross‐reactive Dau c 1‐specific TCC displayed a lower expression of the gut‐homing marker integrin β7 and a significantly higher expression of integrin β1 than non‐cross‐reactive clones (Table [3](#all12938-tbl-0003){ref-type="table-wrap"}). The latter has been associated with recruitment of T cells to the lung [17](#all12938-bib-0017){ref-type="ref"}. Accordingly, we speculate that Dau c 1 primes T cells in the gut which may not cross‐react with Bet v 1. On the other hand, Bet v 1 primes T cells in the lung which then may cross‐react with Dau c 1.

In summary, we found several indications of a Bet v 1‐independent T‐cell response to Dau c 1 in birch pollen‐allergic patients with carrot allergy. Thus, in addition to cross‐reactivity with the major birch pollen allergen, Dau c 1 itself may show sensitizing activity. This evidence is supported by the demonstration of Bet v 1‐independent IgE responses to Dau c 1 in patients [1](#all12938-bib-0001){ref-type="ref"}, [9](#all12938-bib-0009){ref-type="ref"}, [12](#all12938-bib-0012){ref-type="ref"}, [13](#all12938-bib-0013){ref-type="ref"} and by immunological properties of Dau c 1 that are characteristic for sensitizing allergens, namely high stability to endolysosomal proteolysis and the existence of major T‐cell‐activating regions. We conclude that Dau c 1 has a special status among Bet v 1‐related food allergens. These insights are relevant for the treatment of carrot allergy and may explain the limited curative effect of birch pollen immunotherapy on birch pollen‐related food allergy.
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